<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33113361</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2211-1247</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>Cell reports</Title><ISOAbbreviation>Cell Rep</ISOAbbreviation></Journal><ArticleTitle>Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease Genetics.</ArticleTitle><Pagination><StartPage>108323</StartPage><MedlinePgn>108323</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">108323</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2020.108323</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-1247(20)31312-7</ELocationID><Abstract><AbstractText>We meta-analyze amyotrophic lateral sclerosis (ALS) genome-wide association study (GWAS) data of European and Chinese populations (84,694 individuals). We find an additional significant association between rs58854276 spanning ACSL5-ZDHHC6 with ALS (p&#xa0;= 8.3&#xa0;&#xd7; 10<sup>-9</sup>), with replication in an independent Australian cohort (1,502 individuals; p&#xa0;= 0.037). Moreover, B4GALNT1, G2E3-SCFD1, and TRIP11-ATXN3 are identified using a gene-based analysis. ACSL5 has been associated with rapid weight loss, as has another ALS-associated gene, GPX3. Weight loss is frequent in ALS patients and is associated with shorter survival. We investigate the effect of the ACSL5 and GPX3 single-nucleotide polymorphisms (SNPs), using longitudinal body composition and weight data of 77 patients and 77 controls. In patients' fat-free mass, although not significant, we observe an effect in the expected direction (rs58854276: -2.1 &#xb1; 1.3&#xa0;kg/A allele, p&#xa0;= 0.053; rs3828599: -1.0 &#xb1; 1.3&#xa0;kg/A allele, p&#xa0;= 0.22). No effect was observed in controls. Our findings support the increasing interest in lipid metabolism in ALS and link the disease genetics to weight loss in patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iacoangeli</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, King's College London, London, UK; Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK; National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. Electronic address: alfredo.iacoangeli@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, Brisbane, Brisbane QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Khleifat</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Ashley R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opie-Martin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Jonathan R I</ForeName><Initials>JRI</Initials><AffiliationInfo><Affiliation>National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatunov</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sproviero</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie University, Sidney NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garton</LastName><ForeName>Fleur</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, Brisbane, Brisbane QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Restuadi</LastName><ForeName>Restuadi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, Brisbane, Brisbane QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henders</LastName><ForeName>Anjali K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, Brisbane, Brisbane QLD 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mather</LastName><ForeName>Karen A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, UNSW Medicine, University of New South Wales, Sydney NSW, Australia; Neuroscience Research Australia, Randwick NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Merilee</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch Perth WA 6150, Australia; Notre Dame University, 32 Mouat Street, Fremantle WA 6160, Australia; Murdoch University, 90 South Street, Murdoch WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathers</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Calvary Health Care Bethlehem, Parkdale VIC 3195, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Garth A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>ANZAC Research Institute, Concord Repatriation General Hospital, Sydney NSW 2139, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Dominic B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane QLD, Australia; Queensland Brain Institute, The University of Queensland, Brisbane QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCombe</LastName><ForeName>Pamela A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane QLD, Australia; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamphlett</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, The University of Sydney, Sydney NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Flinders Medical Centre, Bedford Park SA 5042, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachdev</LastName><ForeName>Perminder S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, School of Psychiatry, UNSW Medicine, University of New South Wales, Sydney NSW, Australia; Neuropsychiatric Institute, Prince of Wales Hospital, Sydney NSW Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newhouse</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, King's College London, London, UK; National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proitsi</LastName><ForeName>Petroula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fogh</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Shyuan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane QLD, Australia; Queensland Brain Institute, The University of Queensland, Brisbane QLD, Australia; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane QLD, Australia; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson</LastName><ForeName>Richard J B</ForeName><Initials>RJB</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Health Informatics, King's College London, London, UK; National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wray</LastName><ForeName>Naomi R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Institute for Molecular Bioscience, The University of Queensland, Brisbane, Brisbane QLD 4072, Australia; Queensland Brain Institute, The University of Queensland, Brisbane QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyn</LastName><ForeName>Frederik J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, The University of Queensland, Brisbane QLD, Australia; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane QLD, Australia; School of Biomedical Sciences, The University of Queensland, Brisbane QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Chalabi</LastName><ForeName>Ammar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, Department of Basic and Clinical Neuroscience, London, UK; King's College Hospital, Bessemer Road, London SE5 9RS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AL-CHALABI/APR15/844-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L501529/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_17214</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-DOBSON/APR14/829-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ALCHALABI-TALBOT/APR14/926-794</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>171</GrantID><Acronym>ALZS_</Acronym><Agency>Alzheimer's Society</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0600974</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024804/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep</MedlineTA><NlmUniqueID>101573691</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C572507">ZDHHC6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.-</RegistryNumber><NameOfSubstance UI="D000217">Acyltransferases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000217" MajorTopicYN="N">Acyltransferases</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cross-ethnic meta-analysis</Keyword><Keyword MajorTopicYN="N">eQTLs</Keyword><Keyword MajorTopicYN="N">fat-free mass</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">genome-wide association study</Keyword><Keyword MajorTopicYN="N">genomics</Keyword><Keyword MajorTopicYN="N">longitudinal study</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">weight loss</Keyword></KeywordList><CoiStatement>Declaration of Interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>28</Day><Hour>20</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33113361</ArticleId><ArticleId IdType="pmc">PMC7610013</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2020.108323</ArticleId><ArticleId IdType="pii">S2211-1247(20)31312-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrami L., Dallavilla T., Sandoz P.A., Demir M., Kunz B., Savoglidis G., Hatzimanikatis V., van der Goot F.G. Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade. eLife. 2017;6:e27826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5582869</ArticleId><ArticleId IdType="pubmed">28826475</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo K.B., Dent R., Langefeld C.D., Cox M., Williams K., Carrick K.M., Stuart J.S., Sundseth S.S., Harper M.E., McPherson R., Tesson F. Peroxisome proliferator-activated receptor &#x3b3; 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 2007;15:1068&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">17495181</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A. Perspective: Don&#x2019;t keep it in the family. Nature. 2017;550:S112.</Citation><ArticleIdList><ArticleId IdType="pubmed">29045374</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton A., Brooks L.D., Durbin R.M., Garrison E.P., Kang H.M., Korbel J.O., Marchini J.L., McCarthy S., McVean G.A., Abecasis G.R., 1000 Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D., M&#xe4;chler M., Bolker B., Walker S. Fitting linear mixed-effects models using lme4. arXiv. 2014;1406:5823. https://arxiv.org/abs/1406.5823</Citation></Reference><Reference><Citation>Bean D.M., Al-Chalabi A., Dobson R.J.B., Iacoangeli A. A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis. Genes (Basel) 2020;11:668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349022</ArticleId><ArticleId IdType="pubmed">32575372</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B., He J., Zhao Q., Gratten J., Garton F., Leo P.J., Liu Z., Mangelsdorf M., Al-Chalabi A., Anderson L. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat. Commun. 2017;8:611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhris A., Schule R., Loureiro J.L., Louren&#xe7;o C.M., Mundwiller E., Gonzalez M.A., Charles P., Gauthier J., Rekik I., Acosta Lebrigio R.F. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am. J. Hum. Genet. 2013;93:118&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710753</ArticleId><ArticleId IdType="pubmed">23746551</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks W.S., Banerjee S., Crawford D.F. G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization. Exp. Cell Res. 2007;313:665&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1876774</ArticleId><ArticleId IdType="pubmed">17239372</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N.&#xa0;Engl. J. Med. 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers J. Statistical Models in S, J. Chambers and T.J. Hastie. Wadsworth &amp; Brooks/Cole Advanced Books &amp; Software; 1992. Linear models; pp. 95&#x2013;144.</Citation></Reference><Reference><Citation>Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4 s13742-015-0047-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4342193</ArticleId><ArticleId IdType="pubmed">25722852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti F.L., Spataro R., Sproviero W., Mazzei R., Cavalcanti F., Condino F., Simone I.L., Logroscino G., Patitucci A., Magariello A. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology. 2012;79:2315&#x2013;2320.</Citation><ArticleIdList><ArticleId IdType="pubmed">23197749</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw C.A., Mooij J.M., Heskes T., Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 2015;11:e1004219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dempster P., Aitkens S. A new air displacement method for the determination of human body composition. Med. Sci. Sports Exerc. 1995;27:1692&#x2013;1697.</Citation><ArticleIdList><ArticleId IdType="pubmed">8614327</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Truong T.C., Vallat J.M., Sautereau D., Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>eGTEx Project Enhancing GTEx by bridging the gaps between genotype, gene expression, and disease. Nat. Genet. 2017;49:1664&#x2013;1670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636856</ArticleId><ArticleId IdType="pubmed">29019975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara D., Pasetto L., Bonetto V., Basso M. Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis. Front. Neurosci. 2018;12:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107782</ArticleId><ArticleId IdType="pubmed">30174585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I., Ratti A., Gellera C., Lin K., Tiloca C., Moskvina V., Corrado L., Sorar&#xf9; G., Cereda C., Corti S., SLAGEN Consortium and Collaborators A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 2014;23:2220&#x2013;2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>Follit J.A., San Agustin J.T., Xu F., Jonassen J.A., Samtani R., Lo C.W., Pazour G.J. The Golgin GMAP210/TRIP11 anchors IFT20 to the Golgi complex. PLoS Genet. 2008;4:e1000315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2602600</ArticleId><ArticleId IdType="pubmed">19112494</ArticleId></ArticleIdList></Reference><Reference><Citation>Gispert S., Kurz A., Waibel S., Bauer P., Liepelt I., Geisen C., Gitler A.D., Becker T., Weber M., Berg D. The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol. Dis. 2012;45:356&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">21889984</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;gg S., Ganna A., Van Der Laan S.W., Esko T., Pers T.H., Locke A.E., Berndt S.I., Justice A.E., Kahali B., Siemelink M.A., GIANT Consortium Gene-based meta-analysis of genome-wide association studies implicates new loci involved in obesity. Hum. Mol. Genet. 2015;24:6849&#x2013;6860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643645</ArticleId><ArticleId IdType="pubmed">26376864</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlalka G.V., Lehman A., Chioza B., Baple E.L., Maroofian R., Cross H., Sreekantan-Nair A., Priestman D.A., Al-Turki S., McEntagart M.E. Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain. 2013;136:3618&#x2013;3624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859217</ArticleId><ArticleId IdType="pubmed">24103911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou N., Yang Y., Scott I.C., Lou X. The Sec domain protein Scfd1 facilitates trafficking of ECM components during chondrogenesis. Dev. Biol. 2017;421:8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">27851892</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Jones A.R., Sproviero W., Shatunov A., Opie-Martin S., Morrison K.E., Shaw P.J., Shaw C.E., Fogh I., Alzheimer&#x2019;s Disease Neuroimaging Initiative C9orf72 intermediate expansions of 24-30 repeats are associated with ALS. Acta Neuropathol. Commun. 2019;7:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6637621</ArticleId><ArticleId IdType="pubmed">31315673</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A., Al Khleifat A., Sproviero W., Shatunov A., Jones A.R., Opie-Martin S., Naselli E., Topp S.D., Fogh I., Hodges A. ALSgeneScanner: a pipeline for the analysis and interpretation of DNA sequencing data of ALS patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567555</ArticleId><ArticleId IdType="pubmed">30835568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides Z., Steyn F., Mi J., Henderson R., Mccombe P., Ngo S. Predictions of resting energy expenditure in amyotrophic lateral sclerosis are greatly impacted by reductions in fat free mass. Cogent. Med. 2017;4:1343000.</Citation></Reference><Reference><Citation>Ioannides Z.A., Steyn F.J., Henderson R.D., Mccombe P.A., Ngo S.T. Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:486&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28446030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071&#x2013;1078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2906700</ArticleId><ArticleId IdType="pubmed">19847258</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., ITALSGEN Consortium Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 1994;8:221&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">7874163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk S.E., Tracey T.J., Steyn F.J., Ngo S.T. Biomarkers of metabolism in amyotrophic lateral sclerosis. Front. Neurol. 2019;10:191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431787</ArticleId><ArticleId IdType="pubmed">30936848</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S., Hendricks M., Kollewe K., Zapf A., Dengler R., Silani V., Petri S. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3717067</ArticleId><ArticleId IdType="pubmed">23848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Langhardt J., Flehmig G., Kl&#xf6;ting N., Lehmann S., Ebert T., Kern M., Sch&#xf6;n M.R., G&#xe4;rtner D., Lohmann T., Dressler M. Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity. Obes. Facts. 2018;11:475&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6341324</ArticleId><ArticleId IdType="pubmed">30537708</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiela M.J., Chanock S.J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics. 2015;31:3555&#x2013;3557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626747</ArticleId><ArticleId IdType="pubmed">26139635</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A., Ferrari R., Heutink P., Hardy J., Pijnenburg Y., Posthuma D., International FTD-Genomics Consortium Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia. Brain. 2017;140:1437&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28387812</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M., Al-Chalabi A., Andersen P.M., Hosler B., Sapp P., Englund E., Mitchell J.E., Habgood J.J., de Belleroche J., Xi J. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006;66:839&#x2013;844.</Citation><ArticleIdList><ArticleId IdType="pubmed">16421333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., van Eijk R.P.A., Chachay V., van den Berg L.H., McCombe P.A., Henderson R.D., Steyn F.J. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:497&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A., Kenna K.P., Renton A.E., Ticozzi N., Faghri F., Chia R., Dominov J.A., Kenna B.J., Nalls M.A., Keagle P. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12499305</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev P.S., Lammel A., Trollor J.N., Lee T., Wright M.J., Ames D., Wen W., Martin N.G., Brodaty H., Schofield P.R., OATS research team A comprehensive neuropsychiatric study of elderly twins: the Older Australian Twins Study. Twin Res. Hum. Genet. 2009;12:573&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">19943720</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A., Mok K., Newhouse S., Weale M.E., Smith B., Vance C., Johnson L., Veldink J.H., van Es M.A., van den Berg L.H. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010;9:986&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257853</ArticleId><ArticleId IdType="pubmed">20801717</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits P., Bolton A.D., Funari V., Hong M., Boyden E.D., Lu L., Manning D.K., Dwyer N.D., Moran J.L., Prysak M. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N.&#xa0;Engl. J. Med. 2010;362:206&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108191</ArticleId><ArticleId IdType="pubmed">20089971</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Ioannides Z.A., van Eijk R.P.A., Heggie S., Thorpe K.A., Ceslis A., Heshmat S., Henders A.K., Wray N.R., van den Berg L.H. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J.&#xa0;Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazelaar G.H.P., Boeynaems S., De Decker M., van Vugt J.J.F.A., Kool L., Goedee H.S., McLaughlin R.L., Sproviero W., Iacoangeli A., Moisse M., Project MinE ALS Sequencing Consortium ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. Brain Commun. 2020;2:a064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425293</ArticleId><ArticleId IdType="pubmed">32954321</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng A.C., Adamo K., Tesson F., Stewart A.F. Functional characterization of a promoter polymorphism that drives ACSL5 gene expression in skeletal muscle and associates with diet-induced weight loss. FASEB J. 2009;23:1705&#x2013;1709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934840</ArticleId><ArticleId IdType="pubmed">19218499</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek R.A.A., van Rheenen W., Pulit S.L., Kenna K.P., van den Berg L.H., Veldink J.H., Project MinE ALS Sequencing Consortium The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A., V&#xf5;sa U., de Jong S., Robinson M.R., PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Group Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Al-Chalabi A., Ruddy D., Smith B.N., Hu X., Sreedharan J., Siddique T., Schelhaas H.J., Kusters B., Troost D. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129:868&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pubmed">16495328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Ying Z., Wang G. Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains. J.&#xa0;Biol. Chem. 2012;287:28576&#x2013;28585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3436588</ArticleId><ArticleId IdType="pubmed">22761419</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K., Taskesen E., van Bochoven A., Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 2017;8:1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer C.J., Li Y., Abecasis G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>